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Abstract
Here we present the first global functional analysis of cellular responses to pore-forming toxins (PFTs). PFTs are uniquely
important bacterial virulence factors, comprising the single largest class of bacterial protein toxins and being important for
the pathogenesis in humans of many Gram positive and Gram negative bacteria. Their mode of action is deceptively simple,
poking holes in the plasma membrane of cells. The scattered studies to date of PFT-host cell interactions indicate a handful
of genes are involved in cellular defenses to PFTs. How many genes are involved in cellular defenses against PFTs and how
cellular defenses are coordinated are unknown. To address these questions, we performed the first genome-wide RNA
interference (RNAi) screen for genes that, when knocked down, result in hypersensitivity to a PFT. This screen identifies 106
genes (,0.5% of genome) in seven functional groups that protect Caenorhabditis elegans from PFT attack. Interactome
analyses of these 106 genes suggest that two previously identified mitogen-activated protein kinase (MAPK) pathways, one
(p38) studied in detail and the other (JNK) not, form a core PFT defense network. Additional microarray, real-time PCR, and
functional studies reveal that the JNK MAPK pathway, but not the p38 MAPK pathway, is a key central regulator of PFT-
induced transcriptional and functional responses. We find C. elegans activator protein 1 (AP-1; c-jun, c-fos) is a downstream
target of the JNK-mediated PFT protection pathway, protects C. elegans against both small-pore and large-pore PFTs and
protects human cells against a large-pore PFT. This in vivo RNAi genomic study of PFT responses proves that cellular
commitment to PFT defenses is enormous, demonstrates the JNK MAPK pathway as a key regulator of transcriptionally-
induced PFT defenses, and identifies AP-1 as the first cellular component broadly important for defense against large- and
small-pore PFTs.
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Introduction
Pore-forming toxins (PFTs) are proteinaceous virulence factors
that play a major role in bacterial pathogenesis [1,2,3]. PFTs
constitute the single largest class of bacterial virulence factors,
comprising ,25–30% of all bacterial protein toxins [3,4]. PFTs
have been demonstrated to be important in vivo virulence factors
for Staphylococcus aureus, Group A and B streptococci, Streptococcus
pneumoniae, Enterococcus faecalis, uropathogenic Escherichia coli,
Clostridium septicum, and Vibrio cholerae [2,5,6,7,8]. There are various
ways of grouping PFTs, based on the structure of the pore, based
on their pore size as determined by structural or functional data,
or even based on the organisms that produce them [9,10]. With
regards to pore size, they generally can be grouped into two
categories, those that form small (1–2 nm) diameter pores and
those that form large ($30 nm) diameter pores [9,10]. Regardless
of these groupings, PFTs as a class play a singularly important role
in bacterial pathogenesis in mammals.
The mode of PFT action is simple yet elegant—they poke holes
in the plasma membrane, breaching cellular integrity and
disrupting ion balances and membrane potential [10]. As a
consequence, cells die or malfunction, which significantly aids
bacterial pathogenesis. Although unregulated pores at the cell
surface might be expected to be catastrophic, cells have apparently
evolved some mechanisms to protect against low-moderate doses
of PFTs. First shown in Caenorhabditis elegans and then demonstrat-
ed in mammalian cells, the p38 mitogen-activated protein kinase
(MAPK) pathway was the first intracellular pathway demonstrated
to protect cells against PFTs [11,12,13,14]. C. elegans animals or
mammalian cells lacking p38 MAPK are more susceptible to
PLoS Pathogens | www.plospathogens.org 1 March 2011 | Volume 7 | Issue 3 | e1001314killing by PFTs. Three different downstream targets of the p38
PFT defense pathway were identified in C. elegans—two toxin-
regulated targets of MAPK called ttm-1 and ttm-2, and the IRE-1 –
XBP-1 unfolded protein response (UPR) pathway [11,14]. The ttm
genes and the UPR are all required for PFT defenses, are all
induced by crystal toxin PFT in C. elegans, and all require the p38
pathway for their induction. Conserved induction of the UPR in
mammalian cells by a PFT that makes similar in size to crystal
toxin was demonstrated [14]. A few other scattered studies have
identified hypoxia inducible factor (hif-1), wwp-1 (part of the insulin
pathway), and sterol regulatory element binding protein (SREBP)
as involved in cellular defenses against PFTs [15,16,17].
These studies raise the question as to how extensive cellular
defenses to PFT attack are. In a broader sense, since PFTs likely act
similar to membrane damage that occurs in daily the life of cell
[3,10], these studies raise the question as to how cells deal with
unregulated holes at their membranes. How many genes are
involved? Are PFT defenses relatively limited or are they extensive?
Isthereacoordinatedpathwayfordefensiveresponsesoraremultiple
parallel pathways involved? Little work has been done in this area
since it was assumed that unregulated pores at the membrane are
catastrophic, likely leading to osmotic lysis. In essence, PFT attack
was assumed to be too simple for detailed scientific research.
To address the extent to which cells respond to PFT attack, we
report here on the first high-level systematic study of PFT responses
in cells. Namely, we perform a C. elegans RNAi screen to charac-
terize on a genome-wide scale the genes involved in PFT defenses.
Follow up of this data led us to investigate the relative importance of
two MAPK pathways in regulating PFT defenses. The combination
of these data with other functional and molecular data using both
small- and large-pore PFTs in C. elegans and mammalian cells reveal
important insights into the extent of their genome that cells employ
to neutralize proteinaceous membrane pores and how cellular
responses to PFTs are regulated.
Results
Genome-Wide RNAi Screen for Genes That Protect
Against a Small-Pore PFT
C. elegans is susceptible to crystal (Cry) protein PFTs, such as
Cry5B, made by the soil bacterium Bacillus thuringiensis (Bt) [18,19].
Based on homology modeling using several available Cry toxin
structures as templates [20], Cry5B is a member of the three-
domain Bt Cry PFTs that generally form small 1–2 nm diameter
pores similar in size to those of a-toxin from S. aureus and cytolysin
from V. cholerae [1,3,21]. To directly demonstrate that Cry5B is a
PFT, we examined the ability of purified, activated Cry5B to
permeabilize artificial phospholipid membranes. Current transi-
tions between open and closed states demonstrate clearly that
Cry5B forms ion channels in planar lipid bilayers (Figure 1A), and
is therefore a functional PFT. Furthermore, the conductance of
the pores is 125pS or less, consistent with that of other Cry toxins
tested under identical experimental conditions [22], and whose
pore size has been determined to be in the 1–1.3 nm radius [23].
Thus, Cry5B intoxication of C. elegans is a valid model of a small-
pore PFT attack upon eukaryotic cells in vivo.
To ascertain globally how extensive cellular commitment to
protection against PFTs is, we performed a genome-wide RNAi
screen using the Ahringer bacterial RNAi feeding library, which
targets 16000+ C. elegans genes or about 85% of the C. elegans
genome [24] (Figure 1B). Each of the 16000+ individual gene
knock-downs were fed Cry5B PFT and assayed in duplicate wells
for the Hpo (hypersensitive to pore-forming toxin) phenotype
(Figure 1C). Hpo animals display a significantly higher level of
intoxication compared to wild-type animals when exposed to a
sublethal PFT dose. Intoxicated animals are dead or pale,
shrunken, and less motile. Several hundred initial hits were
retested for the Hpo phenotype in a second round of semi-
quantitative knock-down assays (see Materials and Methods). At
this round, each gene knock-down was also counter assayed for
health in the absence of PFT attack; RNAi clones that caused
obvious ill health in the absence of PFT were eliminated from
future consideration. RNAi treatments that replicated the Hpo
phenotype in the second round were then subjected to a third
round of testing, namely quantitative mortality assays in the
presence or absence of a fixed dose of Cry5B PFT (10 mg/mL,
triplicate wells). We kept genes for which knock down resulted in
#60% viability on 10 mg/mL PFT relative to empty vector
controls and $83% viability in the absence of PFT relative to
empty vector controls. These criteria were selected to maintain a
balance between gene knock-downs with solid Hpo phenotypes
and relatively good health in the absence of toxin.
One hundred and six gene knock-downs passed the three
rounds of testing (Table 1). Relative to no knock-down controls, 1)
for 92/106 genes, there is #10% lethality in the absence of toxin,
2) for 91/106 genes there is $50% lethality in the presence of
toxin, and 3) there is $4X more lethality in the presence of toxin
than in the absence of toxin for all but two genes. To demonstrate
the robustness of the list, we selected 12 of these hpo genes that
span the range of PFT hypersusceptibility and, in a fourth round
of testing, repeated PFT lethality assays with knock-downs in four
independent trials. All twelve knock-downs were statistically
confirmed to be Hpo relative to no knock-down controls and
healthy in the absence of PFT (Table S1).
Interestingly, of the eight known hpo genes identified in previous
screens and present in the RNAi library, we found all three of the
genes that mutate to a strong Hpo phenotype and none of the four
genes that mutate to a weak to moderate Hpo phenotype (see
Table 1 legend; knock down of the eighth gene is sickly in the
absence of toxin and would have been screened out). Thus, we
have likely identified many of the genes that mutate to a strong
Hpo phenotype and likely missed an equally large number of
genes that mutate to a weak-moderate Hpo phenotype.
The 106 strong hpo genes constitute .0.5% of the C. elegans
genome (,20,000 genes). Based on the Wormbase annotation, we
Author Summary
The plasma membrane surrounds cells and protects their
interior from the environment and from attack by disease-
causing agents like bacteria and viruses. Bacteria that cause
disease have discovered that an effective way to attack cells
is to secrete proteins (pore-forming toxins) that breach, i.e.,
form holes in, the plasma membrane. How cells deal with
and survive this kind of attack is poorly understood. Here,
we report on the first large-scale study of the genes and
mRNA transcripts that respond to pore-forming toxin attack
in cells. We find that a remarkable portion, .0.5%, of the
cell’s genome protects it against pore-forming toxins. These
data led us to look more closely at mitogen-activated
protein kinase pathways as regulators of pore-forming toxin
defenses. We find that half of the PFT-induced protective
response is controlled by a single, conserved signaling
pathway in cells, which controls a complex array of down-
stream targets and which protects against both large pore
and small pore toxins. Our results indicate that defense
against pore-forming toxins is a very ancient defense that
utilizes a much more complex and extensive response in
cells than previously demonstrated.
Genome-Wide RNAi of PFT Defenses
PLoS Pathogens | www.plospathogens.org 2 March 2011 | Volume 7 | Issue 3 | e1001314Figure 1. Genome-wide identification of hpo genes involved in PFT defenses. (A) Cry5B is a PFT. Representative channel current traces
recorded at various holding voltages across a planar lipid bilayer into which activated Cry5B (5–10 mg/mL) was inserted under symmetrical 150 mM
KCl conditions. Upwards jumps at +20mV and downwards jumps at 220mV correspond to the current flowing in channels in the open state.
Dotted lines (marked ‘‘C’’) indicate the zero current, corresponding to all channels being in their closed state. Records show large jumps (marked
with *), corresponding to a channel conductance of 125 pS, and smaller transitions (marked with #) of about 21 pS that may represent
subconductance states of the channel. (B) Flow chart for genome-wide RNAi screening and validation of genes affecting defense to Cry5B.
(C) Photographs of typical Hpo hits in the primary screen. Scale bar: 0.5 mm. (D) Venn diagrams illustrating the distribution of common genes
between the genome-wide Hpo screen and eight other genome-wide RNAi screens in C. elegans.( E) Putative PFT defense networks assembled
from C. elegans interactome databases. Purple circles: previously published hpo genes. Red circles: hpo genes from our RNAi screen. Green circles:
other genes connected to hpo genes within the network. Blue lines: known interactions for hpo genes. Grey lines: interactions based on
interactome.
doi:10.1371/journal.ppat.1001314.g001
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Sequence
name
Gene
name
a Description
Ortholog
and/or
Homolog
c
% Survival
on Cry5B
d
% Survival
on HEPES
e
Double
Verification
f
Cry5B-
DEG
g
G-protein-coupled receptor
C24B9.7 srg-59 GPCR 27 93
C51F7.2 srg-45 GPCR 7 102
F14F8.5 srw-43 GPCR 40 92
F18E3.6 srw-71 GPCR 31 95
Y46H3C.1 srw-100 GPCR 41 99
Ligand and cell surface related
Y26D4A.2 hpo-2 Cysteine rich domain distantly related to the C-type lectin 39 104
F33D11.9 hpo-3 GPI-anchor attachment protein GAA1 H. M. D. 12 100
T05E11.6 hpo-4 GPI-anchor transamidase H. M. D. 13 95
T14G10.7 hpo-5 GPI-anchor transamidase H. M. D. 26 102
T10D4.4 ins-31 Insulin-like peptide 40 105
Y41D4B.16 hpo-6 Mucin-3A H. 27 103 m
F11C1.3 scav-4 Plasma membrane glycoprotein CD36 H. M. D. 37 99 .
Signal transduction
K11E8.1 unc-43 Calcium/calmodulin-dependent protein kinase (CaMKII) H. M. D. 57 100
F39H11.3 cdk-8 Cyclin-dependent serine/threonine protein kinase H. M. D. 40 94
Y38C9A.2 cgp-1 GTP-binding protein H. M. D. 4 98
ZK792.6 let-60 GTP-binding RAS protooncogene H. M. D. 60 99
T07A9.3 kgb-1
b JNK (Jun-N-terminal kinase)-like MAPK H. M. D. 20 93 ! m
ZK470.5 nck-1 NCK adaptor protein 2 H. M. D. 56 96
B0348.4 egl-8 Phospholipase C beta H. M. D. 23 84
T17E9.1 kin-18 Protein serine/threonine kinase H. M. D. 40 87 ! m
F59A6.1 nsy-1
b Protein serine/threonine kinase (MAPKKK) H. M. D. 48 98
C40A11.5 hpo-7 Protein tyrosine phosphatase H. M. 47 85
T15B7.2 hpo-8 Protein tyrosine phosphatase H. M. D. 51 106
F42C5.10 ttm-4 Sarcoplasmic reticulum histidine-rich calcium-binding protein H. 56 98 ! m
Y59A8B.23 gck-3 Ste20-like serine/threonine protein kinase H. M. D. 49 87
F13B10.1 tir-1
b SAM domains and Toll-IL-1 receptor domain H. M. D. 48 96 m
Transcription factor and gene expression
F29G9.4 fos-1 AP-1 transcription factor H. M. D. 36 90 m
T24H10.7 jun-1 AP-1 transcription factor H. M. D. 35 98 m
C05C8.6 hpo-9 BTB/POZ domain H. M. D. 32 101
ZC518.3 ccr-4 CCR4-NOT transcription complex H. M. D. 22 101 !
VC5.4 mys-1 Histone acetyltransferase H. M. D. 37 97 m
F01F1.1 hpo-10 Leucine permease transcriptional regulator H. M. D. 20 102
C07D10.2 bath-44 Meprin-associated Traf homology (MATH) domain H. M. D. 16 87 !
C49H3.5 ntl-4 MOT2 transcription factor H. M. D. 35 84
T13F3.3 nhr-127 Nuclear hormone receptor H. M. D. 43 97
H37N21.1 hpo-11 Nuclear receptor-binding protein H. M. D. 46 98
ZK1193.5 dve-1 SATB transcripton factor H. M. D. 28 83
Transporter
Y54G9A.3 kqt-3 KCNQ-like K+ channel subunits H. M. D. 34 101 !
C42C1.10 hpo-12 Mitochondrial solute carrier protein H. M. D. 17 108
T24H7.5 tat-4 P-type ATPase H. M. D. 42 104 ! m
W09C2.3 mca-1 Plasma membrane Ca2+ ATPase H. M. D. 36 91
R186.5 shw-3 Voltage-gated K+ channel KCNB/KCNC H. M. D. 60 92 !
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name
Gene
name
a Description
Ortholog
and/or
Homolog
c
% Survival
on Cry5B
d
% Survival
on HEPES
e
Double
Verification
f
Cry5B-
DEG
g
Vesicular trafficking
C23H4.1 cab-1 AEX-3 interacting H. M. D. 18 98 m
C37C3.3 vps-32.2 Charged multivesicular body protein H. M. D. 12 92
Y65B4A.3 vps-20 Charged multivesicular body protein H. M. D. 22 99
Y54E10A.2 cogc-1 Conserved oligomeric Golgi complex (COGC) H. M. D. 10 91
Y105E8B.2 exoc-8 Exocyst complex H. M. D. 46 96
Y106G6H.7 sec-8 Exocyst complex H. M. D. 28 105
T07A5.2 unc-50 Golgi component Gmh1p H. M. D. 29 96
ZK370.3 hipr-1 Huntingtin-interacting protein H. M. D. 29 94 ! m
VF39H2L.1 syx-17 SNARE protein H. M. D. 19 105 m
Metabolism
Y105E8A.10 hpo-13 Bile acid beta-glucosidase H. M. D. 27 106
F59G1.1 cgt-3 Ceramide glucosyltransferase H. M. D. 35 92
C31E10.7 hpo-14 Cytochrome B5 H. M. D. 20 96 .
F28D1.11 dpm-3 Dolichol phosphate mannosyltransferase H. 22 102
Y54E5A.1 ttm-5 Fatty acid desaturase H. M. D. 45 94 ! m
C24G6.6 hpo-15 Flavin-containing amine oxidase H. M. D. 51 101 .
R01H2.5 ger-1 GDP-L-fucose synthetase H. M. D. 33 84
M02B7.4 hpo-16 Glycosyltransferase H. M. D. 12 99
R10D12.12 hpo-17 Glycosyltransferase H. M. D. 58 98
F41E6.14 oac-29 Integral membrane O-acyltransferase 25 90
F32D1.2 hpo-18 Mitochondrial F1F0-ATP synthase subunit epsilon D. 31 104 .
F20H11.3 mdh-1 Mitochondrial malate dehydrogenase H. M. D. 39 102 .
ZK353.6 lap-1 Mitochondrial zinc metalloprotease leucine aminopeptidase H. M. D. 48 93
T05H4.5 hpo-19 NADH-cytochrome B5 reductase H. M. D. 53 100 .
Y47D3A.17 obr-1 Oxysterol-binding protein H. M. D. 6 96 !
C10G11.5 pnk-1 Pantothenate kinase H. M. D. 38 86
ZK809.7 prx-2 PeroxiIsomal membrane protein 3 H. M. D. 20 101
F54F2.8 prx-19 Peroxisomal farnesylated protein H. M. D. 54 96 .
F39G3.7 prx-6 Peroxisome assembly factor 2 H. M. D. 21 100
Y110A2AL.12 hpo-20 Phosphatidylinositol-glycan biosynthesis class W protein H. M. D. 59 99
Y37D8A.10 hpo-21 Signal peptidase complex H. M. D. 28 96
C34C6.5 sphk-1 Sphingosine kinase H. M. D. 11 99
Miscellaneous
M01B12.3 arx-7 Actin-related protein (Arp)2/3 complex H. M. D. 30 100
Y37D8A.1 arx-5 Actin-related protein (Arp)2/3 complex H. M. D. 25 91
Y79H2A.6 arx-3 Actin-related protein (Arp)2/3 complex H. M. D. 16 85
B0024.2 col-150 Collagen H. M. D. 37 100
C08B6.7 hpo-22 Dystrophia myotonica-containing WD repeat motif protein H. M. D. 49 108
Y48G8AL.1 hpo-23 E6-AP ubiquitin-protein ligase H. M. D. 38 99
T23D8.7 hpo-24 Eukaryotic translation initiation factor 2C 4 H. M. D. 45 87
F16G10.4 hpo-25 Extracellular protein with cysteine rich structures 18 83
D2024.6 cap-1 F-actin capping protein alpha subunit H. M. D. 42 91
R09B5.1 fbxa-195 F-box protein 52 102
F46E10.11 hpo-26 Fibrillins H. 39 100
C34G6.1 hpo-27 HEAT repeat H. M. D. 21 90
B0336.11 hpo-28 Motile sperm domain H. M. D. 36 93
Y50D7A.4 hpo-29 N-terminal acetyltransferase H. M. D. 49 100
Table 1. Cont.
Genome-Wide RNAi of PFT Defenses
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protein-coupled receptor (GPCR), ligand and cell surface related,
signal transduction, transcription factor and gene expression,
transporter, vesicular trafficking, metabolism, miscellaneous, and
uncharacterized (Figure S1). Thirteen of these genes have been
previously implicated in, or are homologues of genes involved in
innate immunity, indicating that much of the defense against PFTs
is uncharacterized relative to established immune pathways. The
most highly represented group is that containing genes associated
with metabolic activities, suggesting cells may alter metabolism to
mount an appropriate defense and repair in response to PFTs.
Among the 106 hpo genes, we also identified many genes associated
with vesicle trafficking and membrane transporters, both of which
have been previously implicated, but not demonstrated to be
involved, in PFT defenses [25,26]. Other significant groupings
include GPCR, signal transduction, and transcription factor and
gene expression. Such genes might include key components for the
sensing of upstream signals, and downstream effector genes for PFT
defenses [11,13]. We found that the majority of these 106 genes
have orthologs or homologs in fly (71%), mouse (71%), and humans
(75%) (Table 1). Taken together, these findings support the idea
that metazoans employ an extensive and conserved response to
counteract PFTs and breaches of the plasma membrane.
To understand how functional responses against PFTs compare
to responses to other stressors and conditions, we compared our
list of 106 hpo genes with published genome-wide RNAi screens in
C. elegans for hypertonic stress sensitivity [27], osmo-regulation
[28], life-span regulation [29,30], fat content regulation [31],
protein aggregation regulation [32] and irradiation sensitivity [33]
(no other screens involving a challenge related to bacterial
pathogenesis have been published to our knowledge) (Figure 1D).
The comparison revealed a statistically significant (P=0.000051)
overlap of the hpo genes with only one set of genes, those that upon
inactivation lead to reduced life-span [30]. The lack of overlap
with most other biological processes suggests that protection
against small pores involves a specialized protective response and/
or integrates many different responses, none of which are
singularly dominant.
c-Jun N-Terminal Kinase (JNK)-like MAPK but not p38
MAPK is a Master Regulator of Cry5B PFT-Induced
Transcriptional Responses
To make sense of these 106 genes, we mapped potential
interactions among them (along with a few others from our
previous publications) using the C. elegans interactome database
that contains protein-protein interactions and genetic interactions
Sequence
name
Gene
name
a Description
Ortholog
and/or
Homolog
c
% Survival
on Cry5B
d
% Survival
on HEPES
e
Double
Verification
f
Cry5B-
DEG
g
C32E12.3 osr-1 Osmotic stress response protein 58 97
F37C12.2 eip-24 p53-mediated apoptosis protein EI24/PIG8 H. M. D. 28 97 m
R04F11.1 hpo-30 Tight junction claudin 40 93
F55B12.4 hpo-31 tRNA nucleotidyltransferase/poly(A) polymerase H. M. D. 43 98
R144.4 wip-1 WAS/WASL-interacting protein family member 3 H. M. D. 7 90 m
Uncharacterized
C01G8.6 hpo-32 Unknown H. 46 92
F28B1.1 hpo-33 Unknown 2 86
F29G6.3 hpo-34 Unknown 42 97 .
F45H11.3 hpo-35 Unknown 26 94 .
T27C4.2 hpo-36 Unknown 48 105
Y47D7A.10 hpo-37 Unknown 56 104
Y50D7A.5 hpo-38 Unknown 25 95
Y54E10A.16 mab-31 Unknown 51 98
Y61A9LA.9 hpo-39 Unknown 46 94
ZK856.12 hpo-40 Unknown 48 98
C40H5.6 hpo-41 Pseudogene 46 93
F13A7.6 sri-64 Pseudogene 50 101
T10C6.8 hpo-42 Pseudogene 31 95 !
Y18D10A.18 fbxa-121 Pseudogene 40 104
aThe gene names were annotated based on WormBase release WS221. All the previously unnamed genes were named either ttm or hpo based on their phenotypes.
bWe have published ten genes that upon reduction lead to a Hpo phenotype and knew of one other gene in the p38 pathway (tir-1) that is a strong hpo. Of these 11,
three are not in the Ahringer RNAi library (wwp-1, sek-1, pmk-1); one (ire-1), upon RNAi, leads to sickly worms (would have been screened out). Of the remaining seven
genes, four have relatively weak to moderate Hpo phenotypes upon knock down (ttm-1, ttm-2, hif-1,a n dxbp-1) were not found (likely missed due to the lack of
sensitivity associated with a genome-wide RNAi experiment). All three of the remaining genes (nsy-1, tir-1, kgb-1) that upon knock down result in a strong Hpo
phenotype and are otherwise healthy were identified.
cH., M., and D. refer to Homo sapiens, Mus musculus and Drosophila melanogaster, respectively.
d,e% survivals are relative to empty vector controls.
f! indicates the RNAi clones further confirmed in another round of quadruplicate liquid RNAi assays as shown in Table S1.
g‘‘m’’ indicates induction by Cry5B and ‘‘.’’ indicates repression by Cry5B in 3-hour microarray with a 1.5 fold cutoff. DEG=differentially expressed genes.
doi:10.1371/journal.ppat.1001314.t001
Table 1. Cont.
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unbiased approach, a major interconnected network containing
one-third (38) of all the hpo genes emerges. This network contains
at its center two MAPK pathways, the p38 MAPK pathway and
the c-Jun N-terminal kinase (JNK) MAPK pathway (Figure 1E).
Thus, based on interactions from our genome-wide RNAi screen,
we hypothesized that MAPK pathways play a central role in
cellular PFT responses.
The identification of p38 MAPK as important in PFT defenses
in C. elegans, insect, and mammalian cells has been noted above
and characterized in detail [11,12,13,14]. The conservation of the
p38 pathway in PFT defenses suggested it might be the central
regulator of these defenses. On the other hand, the JNK-like
MAPK pathway, in C. elegans represented by the JNK-like MAPK
KGB-1, was briefly noted as playing a role in Cry5B defenses [11]
but not functionally studied in detail in any system. Whether it
might be central to PFT defenses or a peripheral player was
unknown. The quantitative data from our genome-wide RNAi
screen suggested kgb-1 might be important since knock-down
results in a quantitatively strong hypersensitivity to PFT phenotype
(Table 1, Table S1). Knock-down in the MAPKK gene, mek-1,
known to function upstream of KGB-1 JNK-like MAPK [35], also
results in hypersensitivity to PFT (Figure S2).
To determine the relative importance of the JNK and p38
pathways in PFT defenses, we turned to microarray analyses.
Since inductive transcriptional responses are an important part of
MAPK-mediated responses, we hypothesized that, if important for
PFT defenses, KGB-1 might play an important role in PFT-
induced gene transcription.
We previously used microarray analyses to determine to what
extent the p38 MAPK pathway controlled Cry5B PFT-induced
transcriptional responses and to identify two downstream targets of
the p38 pathway, ttm-1 and ttm-2, both of which phenotypically
play a minor role in Cry5B PFT defenses [11]. Here, we carried
out a similar microarray study with the JNK MAPK pathway in
order to determine how many gene transcripts that are normally
induced by Cry5B PFT are dependent upon the JNK pathway for
their induction. We exposed wild-type and kgb-1(um3) JNK-like
MAPK mutant animals either to Cry5B PFT-expressing bacteria
or to bacteria carrying the empty vector (no-toxin control), each
for three hours. The kgb-1(um3) loss-of-function mutant lacks
1.2 kb of genomic DNA and deletes most of the kinase domain
[36,37]. That kgb-1(um3) represents a null mutant is supported by
our Western blotting experiments (see below). RNA was isolated
from these animals in three independent repeats and hybridized to
Affymetrix-based C. elegans whole genome microarrays. We then
compared these data with those found in the p38 MAPK
microarray experiment [11].
From the total of six wild-type expression profiling microarrays
(three repeats for the sek-1 set and three for the kgb-1 set, both with
and without toxin), we found that at a 2-fold cut-off, 572
transcripts were induced in wild-type C. elegans upon exposure to
Cry5B PFT; that number increases to 1117 transcripts if the cut-
off is set to 1.5-fold (P,0.01 for both). Of repressed transcripts, we
found that 707 transcripts repressed at the 2-fold cut-off and 1428
repressed at the 1.5-fold cut-off (P,0.01 for both) (Figure 2A; see
Supporting Information S1 for a complete list of differentially
expressed transcripts). We cross-checked these transcripts with the
106 hpo genes identified above, and found that 15 hpo genes were
induced $1.5 fold and 8 were induced $2 fold. Statistically, there
is a significant enrichment of induced genes on the hpo list
(P=0.00041 and P=0.0148 respectively). In contrast, the overlap
between repressed genes and hpo genes is not significant (P=0.345
with 1.5 fold cutoff, seven gene overlap, and P=0.652 with 2 fold
cut-off, four gene overlap), indicating that the appearance of
repressed genes on the list of hpo genes is likely from random
chance.
We then classified the dependence of all the transcripts ($2-fold
cut-off) into one of four categories: 1) transcripts dependent upon
only the p38 MAPK pathway for their induction or repression by
Cry5B PFT, 2) transcripts dependent upon only the JNK MAPK
pathway for their induction or repression by Cry5B PFT, 3)
transcripts dependent upon both p38 and JNK MAPK pathways
for their induction or repression, and 4) transcripts whose
induction or repression by Cry5B PFT are independent of either
MAPK pathway (Figure 2B). The results of these analyses were
stunning: whereas the p38 MAPK pathway was responsible for
regulating 8% (48/572) and 2% (14/707) of the PFT-induced and
-repressed transcripts respectively, the JNK MAPK pathway
controlled 51% (290/572) and 24% (172/707) of the PFT-induced
and -repressed transcripts respectively. Thus, the JNK pathway
controls more than half of the induced transcripts and more than
six times the total number of transcripts controlled by the p38
pathway. Furthermore, the JNK pathway controls 85% (41/48) of
the p38 MAPK-dependent induced transcripts and 43% (6/14) of
these p38-dependent repressed transcripts. To validate the
microarray data, we chose one up- and one down-regulated gene
from each of the four categories, isolated RNA from three
independent experiments (minus or plus Cry5B PFT), and per-
formed quantitative real-time (qRT) PCR analyses (Figure 2C).
The qRT-PCR results validate the microarray results. Since the
JNK MAPK pathway is important for the PFT-induced trans-
cripts, we predicted the pathway itself would be activated upon
exposure to PFT. We first showed that there is no detectable
KGB-1 protein in kgb-1(um3) mutant animals and further con-
firmed that the JNK-like MAPK pathway is activated in C. elegans
treated with Cry5B PFT (Figure 3A), as has been seen with the
mammalian cell responses to PFTs [38,39]. Interestingly, in kgb-
1(um3) mutant animals, we detected the phosphorylated form of
p38 MAPK (Figure 3A) induced by Cry5B PFT indicating that the
p38 MAPK activation is not directly regulated by KGB-1.
In addition to the fact that JNK MAPK is important for
induction of most of the PFT-induced transcripts, including those
regulated by p38, we wanted to know if JNK MAPK is also
important for induction of PFT-induced transcripts that are
functionally important (e.g., knock-down to Hpo phenotype). We
therefore tested whether or not KGB-1 regulates p38-controlled
transcripts/pathway that play a role in PFT defenses, namely ttm-1
and ttm-2 and the UPR [11,14]. We find that the induction of both
ttm-1 (Figure 2C) and ttm-2 (Figure 3B) in response to PFT is
dependent upon the JNK MAPK pathway. Cry5B PFT-induced
activation of the UPR PFT defense pathway is also dependent
upon JNK MAPK, as ascertained by induction of the downstream
transcriptional target hsp-4 transcript levels and by induction of
xbp-1 splicing (Figure 3B). As with p38 MAPK-dependent
activation of the UPR by PFT [14], JNK-dependent UPR
activation occurs in the intestine in response to Cry5B PFT (the
tissue directly targeted by the PFT; Figure 3C, upper panels) but
not in response to an unrelated stressor like heat (Figure 3C, lower
panels). The UPR-activation data suggest that the JNK pathway
functions cell autonomously in the intestine for PFT defenses. To
confirm this, we performed intestine-specific RNAi of kgb-1, and
found that animals lacking KGB-1 in the intestine are hypersen-
sitive to Cry5B PFT (Figure 3D). Thus, the JNK MAPK pathway
regulates all currently known p38-dependent PFT protection
genes in the target tissue of the PFT.
We next set out to determine, apart from known p38-dependent
PFT defense genes, what other defense genes JNK MAPK might
Genome-Wide RNAi of PFT Defenses
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RNAi list of hpo genes, examined all eight of the genes that are
induced by PFT (2X cut-off), and asked, based on our microarray
data, if their induction is dependent upon either the p38 or JNK
MAPK pathways. We found four of eight (50%) induced hpo genes
(namely kin-18, Y54E5A.1, F42C5.10 and kgb-1 itself) require JNK
MAPK for their induction whereas none of the eight genes require
the p38 MAPK pathway for their induction. The dependence of
these four genes upon the KGB-1 and not the p38 MAPK
pathway for their induction was confirmed via qRT-PCR
(Figure 3E). The same conclusion is reached if one examines
genes required for PFT defenses induced at the 1.5-fold cutoff: 7/
15 or ,50% of these genes are dependent upon JNK; none are
dependent upon SEK-1. Although the p38 MAPK pathway has
been studied in more detail, these data taken together indicate that
the JNK MAPK pathway plays a more central role in coordinating
induced PFT defenses.
Since KGB-1 is a master regulator of ,50% of Cry5B PFT-
responsive genes, including those that are functionally relevant, we
were interested to see how susceptible kgb-1 mutant animals are to
Cry5B PFT attack. Using a dose-dependent lethality assay, we
determined the LC50 (lethal concentrations at which 50% of the
animals die) of the wild-type, sek-1(km4) p38 MAPKK-minus, and
kgb-1(um3) JNK-like MAPK-minus animals treated with Cry5B
PFT for 8 days. We find that both kgb-1(um3) and sek-1(km4)
mutant animals have similar LC50 values and are both significantly
Figure 2. MAPK pathway-dependent transcriptional responses to PFT attack. (A) Heat-map of PFT-responsive genes in microarray
experiments. Cry5B responsive genes with $2-fold induction (yellow) or repression (blue) relative to non-treated animals are shown. Brighter shades
of color correspond to greater fold changes in expression. Different comparisons of treatments are presented at the top of each column. Wt Cry5B:
Fold change in Cry5B-treated/non Cry5B-treated glp-4(bn2) animals. sek-1 Cry5B: Fold change in Cry5B-treated/non Cry5B-treated glp-4(bn2);sek-
1(km4) animals. kgb-1 Cry5B: Fold change in Cry5B-treated/non Cry5B-treated glp-4(bn2);kgb-1(um3) animals. sek-1 basal: Fold change in glp-
4(bn2);sek-1(km4)/glp-4(bn2) animals (both non Cry5B-treated). kgb-1 basal: Fold change in glp-4(bn2);kgb-1(um3)/glp-4(bn2) animals (both non Cry5B-
treated). glp-4(bn2) animals lack a functional germline and have otherwise normal response to Cry5B (see Materials and Methods). Use of these
animals removes a major tissue from the animals, allowing for intestinal mRNAs to represent a larger portion of the total RNA population. The values
in the parenthesis after the slash indicating the number of the genes in each cluster (I and IV strongly up- or down-regulated; II and III moderately up-
or down-regulated), with the values before slash denoting the genes with known PANTHER ontologies. The corresponding enriched PANTHER
biological processes and molecular functions are shown in each cluster indicated with Roman numerals. For genes involved in immunity/defense
processes, we found 14 in cluster II and 22 in cluster III. (B) Summary of number of genes up- and down-regulated by Cry5B, and their dependence
upon KGB-1 and SEK-1. (C) qRT-PCR analysis of selected genes from microarray analysis. Results are the average of three experiments and error bars
are standard error of the mean. Each gene behaved in the qRT-PCR experiment as was found in the microarray experiment. In this and other figures, *
for P#0.05, ** for P#0.01 and *** for P#0.001.
doi:10.1371/journal.ppat.1001314.g002
Genome-Wide RNAi of PFT Defenses
PLoS Pathogens | www.plospathogens.org 8 March 2011 | Volume 7 | Issue 3 | e1001314Figure 3. KGB-1 JNK-like MAPK regulates p38-dependent and -independent pathways involved in PFT defenses. (A) Activation of
KGB-1 by Cry5B PFT. Activation was assessed by Western blotting using antibodies specific for phosphorylated and total KGB-1. a-tubulin served as
an equal-loading control and phosphorylated p38 MAPK was also tested. Specificity of the antibody was verified by probing kgb-1(um3) mutant
animals. The experiment shown is representative of three experiments with similar results. (B) qRT-PCR analysis of known p38 MAPK downstream
target genes in response to PFT. All three target genes are regulated by KGB-1. Average of three experiments, error bars are standard error of the
mean. (C) In vivo induction of Phsp-4::GFP in the intestine by Cry5B requires KGB-1. The strains Phsp-4::GFP and Phsp-4::GFP;kgb-1(um3) were fed
either control E. coli or E. coli expressing Cry5B for 8 hours or shifted to 30uC for 5 hours in the heat shock treatment. Cry5B induces GFP within the
intestinal cells of the strain Phsp-4::GFP but not in the strain containing the kgb-1(um3) mutant. General stress induction of Phsp-4::GFP via heat shock
is independent of KGB-1. The experiment was performed three times and representative worms are shown. Scale bar is 0.2 mm. (D) Intestinal kgb-1 is
required for protection against Cry5B PFT. Intestine-specific knockdown of kgb-1 in VP303 animals are quantitatively hypersensitive to purified Cry5B,
compared to empty vector control (L4440). Results are the average of three different experiments; error bars indicate standard error of the mean. (E)
qRT-PCR analysis of four KGB-1-dependent hpo genes in response to PFT. All these genes show a KGB-1 dependent/SEK-1 independent induction by
Cry5B PFT. Average of three experiments, error bars are standard error of the mean.
doi:10.1371/journal.ppat.1001314.g003
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These results were unexpected since, based on the fact that KGB-1
regulates more PFT-induced genes functionally required for PFT
protection than the p38 pathway, we predicted that kgb-1 mutant
animals would be more hypersensitive to PFT than sek-1 mutant
animals. There are several explanations for this finding. First, it
might suggest that KGB-1, but not SEK-1, transcriptionally
regulates many genes required for induced PFT defenses and also
some genes that inhibit PFT defenses. Such genes could be
temporally segregated—e.g., KGB-1 JNK-like MAPK could
initially up-regulate transcriptional responses that are protective
(our microarray data is taken at 3 hr post-PFT treatment) and
later down-regulate responses that inhibit protection (our LC50
data is taken at 8 days). Eventual down-regulation of protection is
an important part of induced immune responses and serves to
protect cells from the adverse effects of a prolonged or
overwhelming immune response. Such positive and negative
regulation of a cellular response by the JNK pathway is with
precedent [40,41]. Second, it might also suggest that whereas
KGB-1 JNK-like MAPK is a master regulator of transcriptionally-
induced PFT defenses, the p38 pathway may play an important
role in other (e.g., constitutive) PFT defenses, hence resulting in a
more severe sek-1 phenotype than predicted.
JNK MAPK Protects Against Large-Pore PFTs
Given its importance in the hierarchy of coordinating
transcriptionally-induced defenses against a small-pore PFT and
its activation in both C. elegans treated with small-pore PFT (our
data; see above) and mammalian cells treated with large-pore PFT
(referenced above), we hypothesized that JNK MAPK might
broadly coordinate defenses against PFTs—i.e., it might be
required for defense against both small- and large-pore PFTs.
To date, no gene has been shown to play a protective role against
both large- and small-pore PFTs.
We therefore tested whether a large-pore PFT could intoxicate
C. elegans using streptolysin O (SLO). SLO binds to cholesterol in
cell membranes, forms large 30 nm diameter pores (versus 1–2 nm
pores for Cry PFTs), and is an important virulence factor of
human-pathogenic streptococci [42]. The repair of the pores
formed by SLO in mammalian cells membranes is calcium
dependent [25], and a lytic-mutant N402 SLO has been shown to
be defective in generating pores in membranes [43]. Whether
SLO or any other cholesterol-dependent cytolysin affects C. elegans
has not been previously reported.
We find that wild-type C. elegans are intoxicated by wild-type
SLO at 50 mg/mL with 58% of animals killed in calcium-free
medium and 11% killed in calcium-containing medium in 6 days
(Figure 4A). The inhibitory effect of calcium in SLO-mediated
killing of C. elegans is consistent with known effects of SLO on
mammalian cells [25]. Furthermore, the killing of C. elegans by
SLO is completely dependent upon pore formation since wild-type
worms are not killed by the non-lytic SLO mutant N402
(Figure 4B). Thus, the interaction of SLO with C. elegans parallels
that of the toxin with mammalian cells and the intoxication of C.
elegans by SLO is a valid model of large-pore PFT intoxication.
We then tested whether or not JNK is required for defense
against SLO in C. elegans. Wild-type animals and kgb-1(um3)
mutant animals were exposed to SLO at a dose of 50 mg/mL.
Significantly more kgb-1(um3) mutant animals are killed by SLO
than wild-type animals (Figure 4C), demonstrating that the JNK
MAPK pathway is also required for defense against a large-pore
PFT.
AP-1 is a Key Downstream Target of the JNK MAPK PFT
Protection Pathway Against Both Small- and Large-Pore
PFTs and in Mammalian Cells
C. elegans fos-1 and jun-1 were found in our genome-wide RNAi
screen as genes important for defense against Cry5B PFT (Table 1).
Together, these proteins make up the heterodimeric transcription
factor known as activating protein 1 (AP-1). AP-1 is a well-defined
regulator of innate immunity and stress responses in mammalian
cells and a known downstream target of JNK MAKP pathway in
these responses [44]. To date, neither jun-1 nor fos-1 has been
demonstrated to be involved in protective responses in C. elegans
nor in PFT protection in any system.
Both C. elegans AP-1 homologs, fos-1 and jun-1 were found to be
up-regulated by Cry5B PFT in our microarray study (P,0.001).
To confirm their induction, we performed qRT-PCR analysis of
C. elegans jun-1 and fos-1 expression upon treatment with PFT at 1,
2, 4, and 8 hr. Both are robustly induced by Cry5B, with
Table 2. LC50 values along with 95% confidence intervals.
Strain LC50 (mg/mL) 95% CI of LC50
Relative
Sensitivity LC50
WT 10.40 9.54–11.34
kgb-1(um3) 0.084 0.069–0.101 123.8
sek-1(km4) 0.070 0.065–0.076 148.6
Relative sensitivity was calculated by LC50 wild type/LC50 mutant.
doi:10.1371/journal.ppat.1001314.t002
Figure 4. Intoxication of C. elegans by SLO and the requirement
of kgb-1 in protecting C. elegans against SLO. (A) Viability of wild-
type animals is significantly lower than wild-type animals on the
mammalian PFT SLO in calcium-free S-medium. In calcium-complete
medium, SLO shows a dampened toxicity to wild-type animals. (B) The
mammalian PFT SLO mutant, N402, does not intoxicate wile-type C.
elegans in calcium-free S-medium. (C) JNK-like MAPK protects against
mammalian PFTs. Viability of kgb-1 (um3) loss-of-function animals is
significantly lower than wild-type animals on the mammalian PFT SLO
in calcium-free S-medium. Results are the average of three different
experiments; error bars indicate standard error of the mean.
doi:10.1371/journal.ppat.1001314.g004
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jun-1 induction by Cry5B PFT is KGB-1-dependent and SEK-1
independent whereas fos-1 induction is independent of both
(Figure 5B). These inductions are consistent with our microarray
data (1.5-fold cut-off) and demonstrate that jun-1 is a downstream
target of KGB-1 during PFT protective responses.
To quantitate the protective function of AP-1 during small-pore
PFT attack, we performed Cry5B PFT mortality assays using the
available jun-1 mutant, jun-1(gk551) (as opposed to jun-1 RNAi; the
jun-1(gk551) allele is likely a null as it deletes 1.4 kb of DNA from
the jun-1 locus, including the DNA binding domain). We found
that jun-1(gk551) animals are significantly more sensitive than wild-
type animals at all doses of Cry5B tested and overall are ,10 fold
more sensitive to PFT (Figure 5C). This level of jun-1(gk551)
hypersusceptibility to PFTs is greater than that of mutants in other
non-MAPK hpo genes quantitated to date (namely, xbp-1, hif-1,
ttm-1, ttm-2, wwp-1). We also exposed jun-1(gk551) mutant animals
to heat stress, and find that, compared to wild-type animals, they
are actually slightly resistant to heat stress (Figure 5D; Table S2;
Figure S3). When tested against a second form of pathogenic
attack, namely Pseudomonas aeruginosa PA14, we find that jun-
1(gk551) mutant animals are resistant relative to wild-type animals
(Figure 5E, Table S2, Figure S4). Thus, the sensitivity of jun-1
mutant animals to PFT is not due to generally compromised
health and there is specificity in its role as protecting against PFTs.
To determine whether C. elegans jun, like JNK MAPK, is
protective against large-pore PFTs, we treated jun-1(gk551)
animals with 50 mg/mL SLO and compared the percentage killed
to wild-type animals exposed to the same dose. Animals lacking
jun-1 are hypersensitive to SLO PFT in the absence or presence of
calcium, with 82% and 43% killed respectively (Figure 5F; for
wild-type the numbers killed are 58% and 11%). jun-1(gk551)
Figure 5. Induction of jun and fos transcripts by Cry5B PFT and specificity of jun-1 in protecting C. elegans against PFTs. (A) qRT-PCR
results showing time-course of induction of jun-1 and fos-1 by Cry5B PFT. (B) Cry5B-induced jun-1 expression is KGB-1 dependent and SEK-1
independent. Data shown were based on 3 hours of PFT treatment. For A and B, three RNA samples independent from each other and from the
microarray experiments. (C) Viability of wild-type and jun-1(gk551) animals on three different doses of Cry5B PFT. (D, E) Viability of wild-type and jun-
1(gk551) animals on (D) heat stress and (E) P. aeruginosa PA14. For A, B, and C results are the average of at least three different experiments; error
bars indicate standard error of the mean. For D and E, the data presented are a single representative from three independent assays. (F) Viability of
wild-type and jun-1(gk551) loss-of-function animals on the mammalian PFT SLO and N402 SLO in calcium-free S-medium and calcium-containing S-
medium. Results are the average of at least three different experiments; error bars indicate standard error of the mean. (G) Three known p38 MAPK
downstream target genes in response to Cry5B-PFT are regulated via JUN-1. Cry5B-induced ttm-2, hsp-4 and spliced xbp-1 expression is JUN-1
dependent. Cry5B-induced ttm-1, kin-18, Y54E5A.1 and F42C5.10 was not attenuated in jun-1 mutant animals. Results are the average of three
experiments, and error bars are standard error of the mean.
doi:10.1371/journal.ppat.1001314.g005
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SLO in jun-1 mutant animals is dependent upon pore formation
(Figure 5F). Thus, jun-1 is required for C. elegans protection against
both large- and small-pore PFTs. Since KGB-1, as the master
regulator of PFT defenses, controls the induction of p38-
dependent sub-pathways (ttm-1, ttm-2, hsp-4, and xbp-1) and p38-
independent sub-pathways (kin-18, Y54E5A.1, and F42C5.10), we
further examined whether JUN-1 being the downstream of KGB-
1 contributes to these gene regulation. The qRT-PCR analysis in
wild-type versus jun-1(gk551) mutant animals indicated that jun-1 is
required for the Cry5B-triggered ttm-2 and hsp-4 but not ttm-1, kin-
18, Y54E5A.1, and F42C5.10 induction (Figure 5G). Consistently,
we found that increased splicing (activation) of xbp-1 in response to
Cry5B does not occur in jun-1(gk551) mutant animals (Figure 5G).
These results indicate that KGB-1-regulated genes could be
further parsed to be either JUN-1 dependent or independent.
We then considered whether our finding that AP-1 is important
for PFT responses in C. elegans extends to mammalian cells. Using
commercially available antibodies, we found that 125 ng/mL of
lytic, wild-type SLO induces activation (phosphorylation) of c-JUN
in HaCaT cells and that the non-lytic SLO mutant does not
(Figure 6A). To test whether AP-1 is functionally important for
survival of SLO-treated mammalian cells, we employed a transcrip-
tion factor decoy approach [45]. HaCaT cells were simultaneously
exposed to SLO and biotinylated double-stranded deoxyoligonu-
cleotides comprising a consensus AP-1 binding site (decoy oligo-
nucleotide), which competes with AP-1 sites of genomic promoters
for binding of the transcription factor. A mismatched oligonucleo-
tide, which does not bind AP-1, served as a control. The AP-1 decoy
oligonucleotide specifically increased the proportion of pyknotic
nuclei (Figure 6B). The combination of activation and decoy
oligonucleotide data supports the notion that AP-1 is protective
against PFT attack in mammalian cells, as it is in C. elegans.
Discussion
We present the first genome-wide study of functional cellular
responses to a PFT. We identify 106 hpo genes important for
cellular protection against an attack by a small-pore PFT, Cry5B.
Interactome network analysis of these genes emphasizes the
importance of two MAPK pathways, p38 and JNK, in
coordinating this protection. The stringency of our experimental
design led us to all previously known genes that mutate to a strong
Hpo phenotype and none that mutate to a weak to moderate Hpo
phenotype. All of the genes on this list except two are previously
uncharacterized with regards to PFT defenses. A comparison of
the genes induced by PFT with these 106 important for protection
against PFT revealed a statistically significant enrichment of
transcriptionally-induced, but not transcriptionally-repressed,
genes on the list of PFT-protective genes. These data indicate
that transcriptional induction is important for PFT protection.
Our findings demonstrate that .0.5% of genes in the C. elegans
genome play a major role in protection against pore-forming
toxins. This number is large by any standard for a single cellular
process. Given the likely parallels between cellular responses to
pore-forming toxins and membrane ruptures that occur to cells
during their normal existence, these data suggest that cells devote
such a large portion of their genome to protecting against
membrane holes and that this list of genes represents a rich starting
point for understanding how cells cope with PFT attack and
membrane damage. It is interesting to note that plasma membrane
pore-formation has been suggested to play a significant role in
neurological diseases of ageing, such as Alzheimer’s or Parkinson’s
disease [10]. The significant overlap of the 106 hpo PFT protection
genes with genes involved in promoting long life-span, suggest
indeed that small ruptures of the plasma membrane play a
significant role in the aging process. The fact that JNK and AP-1
are important for protection against both large-pore and small-
pore PFTs indicates that at least some of the pathways cells use to
deal with pores of various sizes are conserved, in contrast to
previous suggestions [10,13].
Based on interactome analyses from our genome-wide RNAi
screen, we examined the requirement of the JNK MAPK pathway
forPFTdefenses.JNKMAPKhasnotbeenstudied inanydetailfor
its role in PFT defenses. Indeed, to date the only signal transduction
pathway studied in detail has been the p38 MAPK pathway. Our
study of the JNK MAPK pathway identifies it, and not p38, as the
first master regulator of PFT transcriptionally-induced cellular
protection. This conclusion is based on the following observations
and results: 1) the JNK MAPK pathway is induced in mammalian
and C. elegans cells by small-pore and large-pore PFTs (this study
and others [38,39]; 2) more than 50% of all genes transcriptionally
induced by PFT depend upon the JNK pathway for their induction
(this study); 3) 85% of the p38-dependent PFT-induced transcrip-
tional response is controlled by JNK MAPK (this study); 4) all three
of the known p38-dependent PFT-induced functional responses are
dependent upon JNK (this study); 5) 50% of the hpo genes that
mutate to a strong Hpo phenotype and that are induced by PFTare
dependent upon JNK; and 6) JNK protects against both large and
small-pore PFTs in C. elegans, the first such gene so identified. Our
analyses also identify the first known downstream targets of the
JNK MAPK-regulated PFT protection pathway, namely, kin-18,
jun-1, Y54E5A.1, and F42C5.10. While JNK MAPK is the master
regulator of induced responses, our Western blotting data suggest
that JNK is not hierarchically upstream of p38 MAPK activation in
response to PFT. Based on our findings we propose a model
whereby the JNK pathway converges in parallel on p38-regulated
PFT responsive genes to regulate the transcriptionally-induced
defense response to Cry5B (Figure 6C).
Our genome-wide analyses also led to the discovery of AP-1, a
key regulator of mammalian innate immunity downstream of JNK
and the toll-like receptor (TLR) pathway, as important for defense
against small- and large-pore PFTs in C. elegans and against a large-
pore PFT in mammalian cells. This study is the first to identify AP-1
as involved in immunity in C. elegans. We also demonstrated that the
UPR and ttm-2 Cry5B-induced defense sub-pathways, but not the
ttm-1, kin-18, Y54E5A.1,a n dF42C5.10 Cry5B-induced defense sub-
pathway, are transcriptionally regulated via JUN-1. Thus, AP-1
mediates some, but not all, of JNK-regulated PFT defenses
(Figure 6C). As indicated by our data and reflected in our model,
regulation of transcriptionally-induced cellular defenses against
PFTs involves an intricately connected network of sub-pathways,
withthe JNK pathway hierarchicallyat the top of known regulators.
AP-1 is the first transcription factor to be shown to be broadly
required for metazoan cells to defend against PFTs. Since the
TLR does not appear to be important for C. elegans immunity [46],
our data suggest that the role of the JNK-AP-1 pathway in
protection against PFTs is one of its most ancestral functions,
predating that of its role in TLR-mediated immunity.
In summary, we report the first large-scale functional study of
genes involved in protecting against a small-pore PFTs, place JNK as
the master regulator of known cellular defenses against small- and
large-pore PFTs, and identify AP-1 as an ancient factor conserved
from worms to humans involved in PFT defenses. This study
demonstrates the power of integrated genome-scale approaches in vivo
to provide vital insights and significant breakthroughs into what has
been to date a daunting scientific challenge, namely understanding
defenses against breaches of plasma membrane integrity.
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C. elegans Strains and Microscopy
Strains were maintained at 20uC as described [47], except
strains containing glp-4(bn2), which were maintained at 15uC.
Images for the genome-wide RNAi screen were acquired using an
Olympus SZ60 dissecting microscope. Strain VP303 rde-1(ne219);
kbEx200 [rol-6(su1006);pnhx-2::RDE-1] was provided by Kevin
Strange (Vanderbilt University) [48]. Phsp-4::GFP and Phsp-
4::GFP;kgb-1(um3)) animals were placed on 2% agarose pads
containing 0.1% sodium azide and were imaged on an Olympus
BX60 microscope with a 10x objective.
Toxin Preparation
Purified Cry5B was prepared as described [49] and suspended
either in water for the genome-wide RNAi screen, or dissolved in
20 mM HEPES (pH 8.0) for liquid mortality assays. E. coli-
expressed Cry5B was prepared as described previously [50],
Figure 6. AP-1 protects against mammalian PFTs. (A) Western blot of mammalian c-JUN in HaCaT cells treated with 125 ng/mL SLO for time
indicated. Abbreviations: S: constitutively active version of SLO, N: non-lytic mutant N402 SLO; Co: no-SLO control. (B) HaCaT cells were treated with
SLO and biotinylated AP-1 decoy-oligonucleotide (right panel) or biotinylated control oligonucleotide (left panel). Oligonucleotide is stained red (SA-
Alexa594), and DNA is stained blue (4’,6-diamidino-2-phenylindole/DAPI). The images presented are a single representative from three independent
assays. Cells treated with AP-1 decoy show a greater proportion of intoxicated cells with condensed chromosomes, characteristic of becoming
pyknotic (e.g., white arrowhead). The proportion of pyknotic cells was quantified as described in the Materials and Methods section; the bar graph
shows mean values from three independent experiments (m=mismatched oligonucleotide; AP-1=AP-1 decoy; error bars: standard error of the
mean, P value was determined with paired, one-tailed student’s t-test). (C) A model for interconnected regulation of defense to PFT. The KGB-1 JNK-
like MAPK regulates both p38 MAPK–dependent (e.g., ttm-1, ttm-2, UPR) and p38 MAPK-independent (e.g., jun-1, kin-18) PFT-induced protection
genes. There are also PFT protection genes that, to date, have not been linked to either MAPK pathway.
doi:10.1371/journal.ppat.1001314.g006
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induction in OP50 expression system. For the microarray
experiment, conditions were carried out as described [11].
Cry5B Activation and Ion Channel Currents Recording in
Planar Lipid Bilayers
Solubilized Cry5B protoxin was incubated at 30uC for two
weeks, allowing co-purifying native Bt protease(s) to activate it into
a 59 kDa fragment. The 59 kDa Cry5B was purified by gel
filtration (Superdex 75 16/60). Ionic currents passing through
activated Cry5B proteins (5-10 mg/mL) reconstituted into planar
lipid bilayers were recorded at various holding voltages applied to
phospholipid membranes (phosphatidylethanolamine:phosphati-
dylcholine:cholesterol (7:2:1 w/w)) painted across a 250-mm hole
drilled in a Teflon wall separating two 600-ml chambers filled with
150 mM KCl, 10 mM Tris, pH 9.0. Data were recorded with an
Axopatch-1D amplifier (Axon Instruments, Foster City, CA),
filtered at 600Hz, digitized and analyzed using pClamp6 software
(Axon Instruments) [51].
Genome-Wide RNAi Screen and Liquid RNAi Assays
RNAi feeding for the genome-wide screen was performed in a
24-well format modified from a published protocol [52]. Bacteria
containing each RNAi clone were cultured in 100 mL Luria Broth
media containing 50 mg/mL carbenicillin in a 96-well format for
16–18 hrs. 30 ml of each culture was seeded in one well of a 24-
well plate containing NGM agar, 1 mM IPTG and 50 mg/ml
carbenicillin (each plate was set up in duplicate). For each batch of
RNAi clones tested, empty vector (L4440) and tir-1 RNAi clones
were included as negative (no knock-down) and positive (Hpo)
controls respectively. After overnight incubation, ,20 synchro-
nized RNAi-sensitive rrf-3(pk1426) L1 worms were placed in each
well and allowed to develop to L4 stage at 20uC. 30 mL of total
1 mg purified Cry5B resuspended in water was added to RNAi-fed
worms in each well (rrf-3 mutants have a normal response to
Cry5B [11]). The plates were covered with porous Rayon films
(VWR, West Chester, PA) to allow air exchange. Hypersensitivity
to PFT relative to no knock-down (empty vector) controls was
assessed after 48 hours by light phase microscopy. The initial Hpo
hits were individually retested in duplicate under the same
conditions (second round). In addition, for each RNAi clone, a
single well was set up and treated with water alone (no toxin) to
assay for ill health in the absence of toxin. To be considered a hpo
gene, we looked for lack of ill health and developmental problems
in the no-toxin well and either .50% moderately Hpo animals in
both wells or .33% severely Hpo animals in both wells. Two
hundred and sixty nine such genes were found in total. For the
quantitative validation test (third round), bacteria from these
RNAi hits were cultured overnight, induced with 1mM IPTG for
1 hour at 37uC, and resuspended in S-media. We then added ,20
glp-4(bn2);rrf-3(pk1426) L1 animals to each well of a 48-well plate
with RNAi bacteria (triplicate wells for each clone). The plates
were gently rocked at 25uC for ,30 hours until the animals had
developed to the L4 stage. Then we added 10 mg/mL Cry5B or
20 mM HEPES pH 8.0 control into each well and quantitated the
percentage of worms that were killed after six days at 25uC. The
worm viability was determined based on movement and worms
failed to respond to several gentle touches with a platinum pick
were scored as dead. The survival on each RNAi treatment was
normalized to L4440 treatment in the same batch, to help account
for differences in toxicity from batch to batch of the experiment.
We sequenced the 106 hpo gene clones to confirm their identities.
The quadruplicate repeat triple-well verification was performed
with the similar procedures except that no plate rocking was
performed and data were analyzed via analysis of variance
(ANOVA) and Dunnett’s post-test. Statistical data analyses here
and elsewhere were performed using Prism 5.0 (GraphPad, San
Diego, CA).
For intestinal-specific liquid RNAi, bacteria for kgb-1 RNAi or
L4440 empty vector were first cultured overnight, induced with
1mM IPTG for 1 hour at 37uC, and resuspended in S-media.
Approximately 20 synchronized L1 stage VP303 worms were fed
with kgb-1 or L4440 RNAi in 48 wells plates, grown to the L4 stage
in ,40 hours at 25uC and FUdR was then added to a final
concentration of 200 mM. Then Cry5B to a final concentration of
10 mg/mL or 20 mM HEPES pH 8.0 control were added into
each well and the percentage of worms that were killed after six
days at 25uC was scored. The comparison of survivals between
kgb-1 RNAi and empty control was done with one-tailed Student’s
t-test.
Microarrays and Bioinformatics
The RNA samples were collected from three independent
experiments as described [11]. glp-4(bn2) animals lack a functional
germline and have otherwise normal response to Cry5B [11]. Use
of these animals removes a major tissue from the animals, allowing
for intestinal mRNAs to represent a larger portion of the total
RNA population. Raw microarray datasets were normalized using
Bioconductor’s [53] Robust Multi-array Analysis (RMA) [54,55]
in R language. Linear Models for Microarray Data (LIMMA) [56]
was used to determine a set differentially expressed genes. The
cutoff p-value used was 0.01 with minimum 1.5 or 2 fold change.
The data were clustered to reveal prominent groups of transcripts
with similar changes in expression pattern using a k-means (k=4)
algorithm.
The gene enrichment analysis for microarray was done with
DAVID PANTHER annotation tool [57]. Only enriched
categories with three or more counts and P,0.05 were kept.
The statistical significance of the observed overlap between
different gene lists (e.g., genome-wide RNAi screens, hpo vs.
induced genes) was calculated by a modified Fisher’s exact test
[58]. The PFT immunity interaction network was generated by
combining data from our genome-wide RNAi screen and a
modified C. elegans integrated functional network (WI8<Litera-
ture<Interolog<Genetic) database with several manually curated
interactions [34]. Interactions were only maintained if at least one
of the nodes was hpo. The resulting networks were visualized using
Cytoscape 2.6.3 [59].
Quantitative RT-PCR
Total RNA was isolated from approximately 5,000 L4 worms
and cDNA was made from 2 mg of total RNA with MoMLV-
reverse transcriptase (Promega, Madison, WI) and oligo-dT
primers for 90 minutes at 42uCi n2 0 ml reaction mixtures.
qRT-PCR (triplicate independent experiments, normalization to
eft-2) was then carried out as described [14]. Primers for qRT-
PCR are listed in Table S3 except for eft-2, ttm-2, hsp-4, and xbp-1
spliced form, which have been described before [14,15].
Transcript levels among mutants and wild-type animals for a
given gene were compared using one-way ANOVA with Tukey’s
HSD post hoc test or one-tailed Student’s t-test (Figure 3A and 5G
only).
KGB-1 Immunoblotting
Approximately 750 L1 stage worms were grown in a single well
of a 48 well plate, treated with indicated concentrations of Cry5B
and prepared as described before for phospho p38 MAPK and a-
tubulin [14]. The same PVDF membranes were stripped with
Genome-Wide RNAi of PFT Defenses
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Inc., Waltham, MA) and reprobed as needed. The probing order
is phospho-KGB-1 (1:1000) first, phospho-p38 MAPK and a-
tubulin second, and total KGB-1 antiserum (1:5000) third.
C. elegans Mortality Assays with Mutants
Cry5B mortality assays with wild-type animals and kgb-1 and
sek-1 mutants were carried out for 8 days at 20uC in three
independent experiments as per standard protocol[50]. LC50
values and confidence intervals were calculated as described [60].
For SLO and N402 assays, synchronized L4 worms were prepared
in complete or calcium-free S-medium with 50 mg/mL of toxin
dissolved in phosphate buffered saline (PBS; PBS alone was used in
negative controls). The survival of animals was scored after six
days at 25uC and differences analyzed by analyzed with one-tailed
Student’s t-test. The P. aeruginosa PA14 survival assay was
performed on slow-killing plates as described [14]. For the heat
stress analysis, synchronized N2 and jun-1(gk551) animals were
shifted to 35uC as two-day-old adults and survival was scored
every two hours after the treatment as described [61]. Three
lifespan assays per worm strain were done, and all show the same
trends. The data presented in the paper are from a representative
experiment. Data are plotted as a Kaplan–Meier survival plot and
analyzed for significance using the Log Rank test.
Preparation of SLO and Mammalian Cell Experiments
Recombinant streptolysin O and non-lytic mutant N402 were
prepared as described previously [43,62]. Growth of the human
keratinocyte cell line HaCaT has been previously described [63].
Cells were seeded at a density of 0.5x10
6 cells in 12-well plates,
cultured overnight and treated with 125 ng/ml SLO or non-lytic
mutant N402 for indicated times. After washing with PBS, cells
were lysed by addition of 50 ml 2xSDS-loading buffer. Proteins
were separated by SDS-PAGE and electroblotted onto nitrocel-
lulose membrane, incubated with rabbit anti-phospho Ser63-c-jun
(1:1000; Cell Signaling Technology) over night at 4uC, washed,
and incubated with goat anti-rabbit IgG HRP-conjugate (1:2000;
New England Biolabs). After three washes, bound antibody was
detected by ECL. The same membrane was stripped with TBS
containing 2% SDS and 100 mM b-mercaptoethanol for 50 min
at 50uC and reprobed with rabbit anti-c-jun (1:1000; Cell
Signaling Technology).
For the AP-1 decoy experiment, HaCaT cells were treated in
Ca
2+-free medium with 500 ng/mL SLO and 3 mM biotinylated
AP-1 decoy oligodeoxynucleotide (ODN), or mismatched AP-1
decoy ODN for 30 min, (Genedetect, Auckland, New Zealand).
Subsequently, cells were washed twice with PBS and incubated in
full culture medium. After incubation for 4 hours, cells were fixed
with 4% paraformaldehyde, permeabilized with 0.1% triton-
X100. Biotinylated ODN were stained with AlexaFluor594-
conjugated streptavidin; nuclei were visualized with DAPI stain
(10 mg/mL). After washing, cells were examined by fluorescence
microscopy using an Axiovert 200M microscope (Zeiss, Germany).
The relative intensity of DAPI staining was quantified for ca. 800
cells per treatment and experiment, applying the analysis tool
of Photoshop to digital images in RGB-mode. Nuclei were
considered pyknotic if they were condensed to a diameter,50% of
average and showed more intense DAPI uptake (.2-fold of
average intensity)[64].
Supporting Information
Figure S1 Functional classification of hpo genes based on
Wormbase annotation.
Found at: doi:10.1371/journal.ppat.1001314.s001 (0.11 MB TIF)
Figure S2 A qualitative analysis of the sensitivity of worms with
mek-1(ks54) loss of function mutation. Animals were exposed for
72 hours to OP50 E. coli expressing empty vector (no toxin) or
diluted Cry5B PFT (10%). mek-1 mutant animals are Hpo as they
are significantly more intoxicated by Cry5B PFT than wild-type
animals.
Found at: doi:10.1371/journal.ppat.1001314.s002 (0.65 MB TIF)
Figure S3 jun-1 loss-of-function increases resistance of worms to
heat stress. A and B represent the other two repeats of the heat
stress assays.
Found at: doi:10.1371/journal.ppat.1001314.s003 (0.16 MB TIF)
Figure S4 jun-1 loss-of-function increases resistance of worms to
PA14 infection. A and B represent the other two repeats of the
PA14 life-span assays.
Found at: doi:10.1371/journal.ppat.1001314.s004 (0.17 MB TIF)
Table S1 Further confirmation of a subset of Hpo RNAi clones.
Found at: doi:10.1371/journal.ppat.1001314.s005 (0.03 MB XLS)
Table S2 Statistics for stress response assays.
Found at: doi:10.1371/journal.ppat.1001314.s006 (0.03 MB XLS)
Table S3 Primers sequences for qRT-PCR.
Found at: doi:10.1371/journal.ppat.1001314.s007 (0.03 MB XLS)
Supporting Information S1 Microarray data. Data from
microarray experiments showing all genes 2-fold up and down
following PFT treatment and their dependence upon MAPK
pathways and all genes 1.5-fold up and down following PFT
treatment.
Found at: doi:10.1371/journal.ppat.1001314.s008 (0.87 MB XLS)
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